| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Cell Biology [Y. T., Y. K., C. D. B., L. M. E.], Surgical Oncology [Y. T., L. M. E.], and Pathology [K. R. C.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
We studied the correlation between expression of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and their receptors with vascularity, metastasis, and proliferative index of human colon cancers. Immunohistochemical analyses using antibodies against VEGF, bFGF, their receptors (KDR, flt-1, bek, and flg), factor VIII, and proliferating cell nuclear antigen were carried out on archival specimens of 52 human colon carcinomas and 10 adenomas. Vessels were quantitated by light microscopy (x200), and the intensity of staining for VEGF and bFGF was assessed on a scale of 0–3+. The presence or absence of immunostaining for KDR, flt-1, bek, and flg was evaluated in endothelial cells, and proliferation was determined by counting the number of proliferating cell nuclear antigen-positive cells per 500 tumor cells. Expression of VEGF and KDR was higher in metastatic than in nonmetastatic neoplasms and directly correlated with the extent of neovascularization and the degree of proliferation, whereas expression of bFGF, flt-1, bek, and flg did not differ among tumor types. Vessel counts were greater in metastatic tumors than in nonmetastatic tumors. These findings support the hypothesis that VEGF is an important angiogenic factor in primary and metastatic human colon cancer. VEGF expression and vessel counts may aid in predicting patients at risk for metastasis from colon cancer.
1 This work was supported in part by American Cancer Society Cancer Development Award 94-21 (L. M. E.).
2 To whom requests for reprints should be addressed, at The University of Texas M. D. Anderson Cancer Center, Texas Medical Center, Box 106, 1515 Holcombe Boulevard, Houston, TX 77030.
Received 6/ 5/95. Accepted 6/ 5/95.
This article has been cited by other articles:
|
|
 |
|
  A. Ghanipour, K. Jirstrom, F. Ponten, B. Glimelius, L. Pahlman, and H. Birgisson The Prognostic Significance of Tryptophanyl-tRNA Synthetase in Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 2949 - 2956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Iwasaki and S.-i. Nihira Anti-angiogenic Therapy Against Gastrointestinal Tract Cancers Jpn. J. Clin. Oncol., September 1, 2009; 39(9): 543 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. T. Okita, Y. Yamada, D. Takahari, Y. Hirashima, J. Matsubara, K. Kato, T. Hamaguchi, K. Shirao, Y. Shimada, H. Taniguchi, et al. Vascular Endothelial Growth Factor Receptor Expression as a Prognostic Marker for Survival in Colorectal Cancer Jpn. J. Clin. Oncol., September 1, 2009; 39(9): 595 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Basappa, S. Murugan, K. N Sugahara, C. M. Lee, G. B ten Dam, T. H van Kuppevelt, M. Miyasaka, S. Yamada, and K. Sugahara Involvement of chondroitin sulfate E in the liver tumor focal formation of murine osteosarcoma cells Glycobiology, July 1, 2009; 19(7): 735 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. DOI, M.-A. SHIBATA, E. SHIBATA, J. MORIMOTO, Y. AKAO, M. IINUMA, N. TANIGAWA, and Y. OTSUKI Panaxanthone Isolated from Pericarp of Garcinia mangostana L. Suppresses Tumor Growth and Metastasis of a Mouse Model of Mammary Cancer Anticancer Res, July 1, 2009; 29(7): 2485 - 2495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Kohne and H.-J. Lenz Chemotherapy with Targeted Agents for the Treatment of Metastatic Colorectal Cancer Oncologist, May 1, 2009; 14(5): 478 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Umehara, M. Karhanek, R. W. Davis, and N. Pourmand Label-free biosensing with functionalized nanopipette probes PNAS, March 24, 2009; 106(12): 4611 - 4616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Knopp, C Trope, J M Nesland, and R Holm A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice J. Clin. Pathol., March 1, 2009; 62(3): 212 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wu, Y.-Y. Li, K. Matsushima, T. Baba, and N. Mukaida CCL3-CCR5 Axis Regulates Intratumoral Accumulation of Leukocytes and Fibroblasts and Promotes Angiogenesis in Murine Lung Metastasis Process J. Immunol., November 1, 2008; 181(9): 6384 - 6393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Kanies, J. J. Smith, C. Kis, C. Schmidt, S. Levy, K. S.A. Khabar, J. Morrow, N. Deane, D. A. Dixon, and R. D. Beauchamp Oncogenic Ras and Transforming Growth Factor-{beta} Synergistically Regulate AU-Rich Element-Containing mRNAs during Epithelial to Mesenchymal Transition Mol. Cancer Res., July 1, 2008; 6(7): 1124 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sumitomo, F. Koizumi, T. Asano, A. Horiguchi, K. Ito, T. Asano, T. Kakizoe, M. Hayakawa, and Y. Matsumura Novel SN-38-Incorporated Polymeric Micelle, NK012, Strongly Suppresses Renal Cancer Progression Cancer Res., March 15, 2008; 68(6): 1631 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zabaleta, H.-Y. Lin, R. A. Sierra, M.C. Hall, P. E. Clark, O. A. Sartor, J. J. Hu, and A. C. Ochoa Interactions of cytokine gene polymorphisms in prostate cancer risk Carcinogenesis, March 1, 2008; 29(3): 573 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Salvador, B. Li, R. Hansen, D. E. Cramer, M. Kong, and J. Yan Yeast-Derived {beta}-Glucan Augments the Therapeutic Efficacy Mediated by Anti-Vascular Endothelial Growth Factor Monoclonal Antibody in Human Carcinoma Xenograft Models Clin. Cancer Res., February 15, 2008; 14(4): 1239 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kuwai, T. Nakamura, S.-J. Kim, T. Sasaki, Y. Kitadai, R. R. Langley, D. Fan, S. R. Hamilton, and I. J. Fidler Intratumoral Heterogeneity for Expression of Tyrosine Kinase Growth Factor Receptors in Human Colon Cancer Surgical Specimens and Orthotopic Tumors Am. J. Pathol., February 1, 2008; 172(2): 358 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Xiao and S. V. Singh z-Guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, inhibits angiogenesis in vitro and in vivo Mol. Cancer Ther., January 1, 2008; 7(1): 171 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Calviello, F. Resci, S. Serini, E. Piccioni, A. Toesca, A. Boninsegna, G. Monego, F. O. Ranelletti, and P. Palozza Docosahexaenoic acid induces proteasome-dependent degradation of {beta}-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2 Carcinogenesis, June 1, 2007; 28(6): 1202 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Langley and I. J. Fidler Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis Endocr. Rev., May 1, 2007; 28(3): 297 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zhou, Y. Zhai, Y. Cui, X. Zhang, X. Dong, H. Yang, Y. He, K. Yao, H. Zhang, L. Zhi, et al. MDM2 Promoter SNP309 Is Associated with Risk of Occurrence and Advanced Lymph Node Metastasis of Nasopharyngeal Carcinoma in Chinese Population Clin. Cancer Res., May 1, 2007; 13(9): 2627 - 2633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Wang, H. Wang, Y. Guo, W. Ning, S. Katkuri, W. Wahli, B. Desvergne, S. K. Dey, and R. N. DuBois From the Cover: Crosstalk between peroxisome proliferator-activated receptor {delta} and VEGF stimulates cancer progression PNAS, December 12, 2006; 103(50): 19069 - 19074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Jost, H.-P. Gschwind, T. Jalava, Y. Wang, C. Guenther, C. Souppart, A. Rottmann, K. Denner, F. Waldmeier, G. Gross, et al. Metabolism and Disposition of Vatalanib (PTK787/ZK-222584) in Cancer Patients Drug Metab. Dispos., November 1, 2006; 34(11): 1817 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Koizumi, M. Kitagawa, T. Negishi, T. Onda, S.-i. Matsumoto, T. Hamaguchi, and Y. Matsumura Novel SN-38-Incorporating Polymeric Micelles, NK012, Eradicate Vascular Endothelial Growth Factor-Secreting Bulky Tumors. Cancer Res., October 15, 2006; 66(20): 10048 - 10056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-Y. Yang, C. S. Zong, W. Xia, Y. Wei, M. Ali-Seyed, Z. Li, K. Broglio, D. A. Berry, and M.-C. Hung MDM2 Promotes Cell Motility and Invasiveness by Regulating E-Cadherin Degradation. Mol. Cell. Biol., October 1, 2006; 26(19): 7269 - 7282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Heidemann, D G Binion, W Domschke, and T Kucharzik Antiangiogenic therapy in human gastrointestinal malignancies. Gut, October 1, 2006; 55(10): 1497 - 1511. [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. Giesel, H. Bischoff, H. von Tengg-Kobligk, M.-A. Weber, C. M. Zechmann, H.-U. Kauczor, and M. V. Knopp Dynamic Contrast-Enhanced MRI of Malignant Pleural Mesothelioma: A Feasibility Study of Noninvasive Assessment, Therapeutic Follow-up, and Possible Predictor of Improved Outcome Chest, June 1, 2006; 129(6): 1570 - 1576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Lucidarme, Y. Kono, J. Corbeil, S.-H. Choi, J.-L. Golmard, J. Varner, and R. F. Mattrey Angiogenesis: Noninvasive Quantitative Assessment with Contrast-enhanced Functional US in Murine Model. Radiology, June 1, 2006; 239(3): 730 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 {blacktriangledown}Bevacizumab and {blacktriangledown}cetuximab for colorectal cancer DTB, May 1, 2006; 44(5): 37 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Mulkeen, T. Silva, P. S. Yoo, J. C. Schmitz, E. Uchio, E. Chu, and C. Cha Short Interfering RNA-Mediated Gene Silencing of Vascular Endothelial Growth Factor: Effects on Cellular Proliferation in Colon Cancer Cells Arch Surg, April 1, 2006; 141(4): 367 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-T. Zhou, Y. Yang, and J.-P. Ge The preventive effect of salvianolic acid B on malignant transformation of DMBA-induced oral premalignant lesion in hamsters Carcinogenesis, April 1, 2006; 27(4): 826 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Yance Jr and S. M. Sagar Targeting Angiogenesis With Integrative Cancer Therapies Integr Cancer Ther, March 1, 2006; 5(1): 9 - 29. [Abstract] [PDF]
|
|
|
|
 |
|
 C. H. Crane, L. M. Ellis, J. L. Abbruzzese, C. Amos, H. Q. Xiong, L. Ho, D. B. Evans, E. P. Tamm, C. Ng, P. W.T. Pisters, et al. Phase I Trial Evaluating the Safety of Bevacizumab With Concurrent Radiotherapy and Capecitabine in Locally Advanced Pancreatic Cancer J. Clin. Oncol., March 1, 2006; 24(7): 1145 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sun, S. Stevanovic, M. Song, A. Schwantes, C. J. Kirkpatrick, D. Schadendorf, and K. Cichutek The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes Blood, February 15, 2006; 107(4): 1476 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Hoff, R. A. Wolff, K. Bogaard, S. Waldrum, and J. L. Abbruzzese A Phase I Study of Escalating Doses of the Tyrosine Kinase Inhibitor Semaxanib (SU5416) in Combination with Irinotecan in Patients with Advanced Colorectal Carcinoma Jpn. J. Clin. Oncol., February 1, 2006; 36(2): 100 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Miyata, S. Kanda, K. Ohba, K. Nomata, Y. Hayashida, J. Eguchi, T. Hayashi, and H. Kanetake Lymphangiogenesis and Angiogenesis in Bladder Cancer: Prognostic Implications and Regulation by Vascular Endothelial Growth Factors-A, -C, and -D Clin. Cancer Res., February 1, 2006; 12(3): 800 - 806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Garton, A. P.A. Crew, M. Franklin, A. R. Cooke, G. M. Wynne, L. Castaldo, J. Kahler, S. L. Winski, A. Franks, E. N. Brown, et al. OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models Cancer Res., January 15, 2006; 66(2): 1015 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kuramochi, K. Hayashi, K. Uchida, S. Miyakura, D. Shimizu, D. Vallbohmer, S. Park, K. D. Danenberg, K. Takasaki, and P. V. Danenberg Vascular Endothelial Growth Factor Messenger RNA Expression Level Is Preserved in Liver Metastases Compared with Corresponding Primary Colorectal Cancer Clin. Cancer Res., January 1, 2006; 12(1): 29 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Cristi, G Perrone, G Toscano, A Verzi, S Nori, D Santini, G Tonini, A Vetrani, A Fabiano, and C Rabitti Tumour proliferation, angiogenesis, and ploidy status in human colon cancer J. Clin. Pathol., November 1, 2005; 58(11): 1170 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. F. Kabbinavar, J. Schulz, M. McCleod, T. Patel, J. T. Hamm, J. R. Hecht, R. Mass, B. Perrou, B. Nelson, and W. F. Novotny Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial J. Clin. Oncol., June 1, 2005; 23(16): 3697 - 3705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lopez de Cicco, D. E. Bassi, S. Zucker, N. G. Seidah, and A. J.P. Klein-Szanto Human Carcinoma Cell Growth and Invasiveness Is Impaired by the Propeptide of the Ubiquitous Proprotein Convertase Furin Cancer Res., May 15, 2005; 65(10): 4162 - 4171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Lee, D. Lopes de Menezes, J. Vora, A. Harris, H. Ye, L. Nordahl, E. Garrett, E. Samara, S. L. Aukerman, A. B. Gelb, et al. In vivo Target Modulation and Biological Activity of CHIR-258, a Multitargeted Growth Factor Receptor Kinase Inhibitor, in Colon Cancer Models Clin. Cancer Res., May 15, 2005; 11(10): 3633 - 3641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S-C Wei, P-N Tsao, S-C Yu, C-T Shun, J-J Tsai-Wu, C H H Wu, Y-N Su, F-J Hsieh, and J-M Wong Placenta growth factor expression is correlated with survival of patients with colorectal cancer Gut, May 1, 2005; 54(5): 666 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Hicklin and L. M. Ellis Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis J. Clin. Oncol., February 10, 2005; 23(5): 1011 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Calviello, F. Di Nicuolo, S. Gragnoli, E. Piccioni, S. Serini, N. Maggiano, G. Tringali, P. Navarra, F. O. Ranelletti, and P. Palozza n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1{alpha} induction pathway Carcinogenesis, December 1, 2004; 25(12): 2303 - 2310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Pasquier, M. Carre, B. Pourroy, L. Camoin, O. Rebai, C. Briand, and D. Braguer Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway Mol. Cancer Ther., October 1, 2004; 3(10): 1301 - 1310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Emanuel, R. H. Gruninger, A. Fuentes-Pesquera, P. J. Connolly, J. A. Seamon, S. Hazel, R. Tominovich, B. Hollister, C. Napier, M. R. D'Andrea, et al. A Vascular Endothelial Growth Factor Receptor-2 Kinase Inhibitor Potentiates the Activity of the Conventional Chemotherapeutic Agents Paclitaxel and Doxorubicin in Tumor Xenograft Models Mol. Pharmacol., September 1, 2004; 66(3): 635 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. de Cicco, J. C. Watson, D. E. Bassi, S. Litwin, and A. J. Klein-Szanto Simultaneous Expression of Furin and Vascular Endothelial Growth Factor in Human Oral Tongue Squamous Cell Carcinoma Progression Clin. Cancer Res., July 1, 2004; 10(13): 4480 - 4488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Brieger, M. Wierzbicka, M. Sokolov, Y. Roth, W. Szyfter, and W. J. Mann Vessel Density, Proliferation, and Immunolocalization of Vascular Endothelial Growth Factor in Juvenile Nasopharyngeal Angiofibromas Arch Otolaryngol Head Neck Surg, June 1, 2004; 130(6): 727 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T C Mineo, V Ambrogi, A Baldi, C Rabitti, P Bollero, B Vincenzi, and G Tonini Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer J. Clin. Pathol., June 1, 2004; 57(6): 591 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Parikh, F. Fan, W. B. Liu, S. A. Ahmad, O. Stoeltzing, N. Reinmuth, D. Bielenberg, C. D. Bucana, M. Klagsbrun, and L. M. Ellis Neuropilin-1 in Human Colon Cancer: Expression, Regulation, and Role in Induction of Angiogenesis Am. J. Pathol., June 1, 2004; 164(6): 2139 - 2151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H. Fernando and H. I. Hurwitz Targeted Therapy of Colorectal Cancer: Clinical Experience with Bevacizumab Oncologist, June 1, 2004; 9(suppl_1): 11 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. R. Santos and S. Dias Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways Blood, May 15, 2004; 103(10): 3883 - 3889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Kim, I. K. Choi, K. H. Park, S. Y. Yoon, S. C. Oh, J. H. Seo, C. W. Choi, B. S. Kim, S. W. Shin, Y. H. Kim, et al. Serum Vascular Endothelial Growth Factor per Platelet Count in Hepatocellular Carcinoma: Correlations with Clinical Parameters and Survival Jpn. J. Clin. Oncol., April 1, 2004; 34(4): 184 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Mizukami, J. Li, X. Zhang, M. A. Zimmer, O. Iliopoulos, and D. C. Chung Hypoxia-Inducible Factor-1-Independent Regulation of Vascular Endothelial Growth Factor by Hypoxia in Colon Cancer Cancer Res., March 1, 2004; 64(5): 1765 - 1772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ray, R. Cabal-Manzano, A. R. Moser, T. Waldman, L. M. Zipper, A. Aigner, S. W. Byers, A. T. Riegel, and A. Wellstein Up-Regulation of Fibroblast Growth Factor-Binding Protein, by {beta}-Catenin during Colon Carcinogenesis Cancer Res., December 1, 2003; 63(23): 8085 - 8089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Ellis Antiangiogenic Therapy: More Promise and, Yet Again, More Questions J. Clin. Oncol., November 1, 2003; 21(21): 3897 - 3899. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Sorvillo, G. Mazziotti, A. Carbone, M. Piscopo, M. Rotondi, M. Cioffi, P. Musto, B. Biondi, S. Iorio, G. Amato, et al. Recombinant Human Thyrotropin Reduces Serum Vascular Endothelial Growth Factor Levels in Patients Monitored for Thyroid Carcinoma Even in the Absence of Thyroid Tissue J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4818 - 4822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-y. Liu, Y.-q. Wei, L. Yang, X. Zhao, L. Tian, J.-m. Hou, T. Niu, F. Liu, Y. Jiang, B. Hu, et al. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2 Blood, September 1, 2003; 102(5): 1815 - 1823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Stoeltzing, S. A. Ahmad, W. Liu, M. F. McCarty, J. S. Wey, A. A. Parikh, F. Fan, N. Reinmuth, M. Kawaguchi, C. D. Bucana, et al. Angiopoietin-1 Inhibits Vascular Permeability, Angiogenesis, and Growth of Hepatic Colon Cancer Tumors Cancer Res., June 15, 2003; 63(12): 3370 - 3377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Fukuda, B. Kelly, and G. L. Semenza Vascular Endothelial Growth Factor Gene Expression in Colon Cancer Cells Exposed to Prostaglandin E2 Is Mediated by Hypoxia-inducible Factor 1 Cancer Res., May 1, 2003; 63(9): 2330 - 2334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Benckert, S. Jonas, T. Cramer, Z. von Marschall, G. Schafer, M. Peters, K. Wagner, C. Radke, B. Wiedenmann, P. Neuhaus, et al. Transforming Growth Factor {beta}1 Stimulates Vascular Endothelial Growth Factor Gene Transcription in Human Cholangiocellular Carcinoma Cells Cancer Res., March 1, 2003; 63(5): 1083 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Cianchi, C. Cortesini, O. Fantappie, L. Messerini, N. Schiavone, A. Vannacci, S. Nistri, I. Sardi, G. Baroni, C. Marzocca, et al. Inducible Nitric Oxide Synthase Expression in Human Colorectal Cancer: Correlation with Tumor Angiogenesis Am. J. Pathol., March 1, 2003; 162(3): 793 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Kabbinavar, H. I. Hurwitz, L. Fehrenbacher, N. J. Meropol, W. F. Novotny, G. Lieberman, S. Griffing, and E. Bergsland Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer J. Clin. Oncol., January 1, 2003; 21(1): 60 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tripodis and P. Demant Genetic Analysis of Three-dimensional Shape of Mouse Lung Tumors Reveals Eight Lung Tumor Shape-Determining (Ltsd) Loci That Are Associated with Tumor Heterogeneity and Symmetry Cancer Res., January 1, 2003; 63(1): 125 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schuch, M. Machluf, G. Bartsch Jr, M. Nomi, H. Richard, A. Atala, and S. Soker In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo Blood, December 15, 2002; 100(13): 4622 - 4628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bellan, G. De Falco, G. M. Tosi, S. Lazzi, F. Ferrari, G. Morbini, S. Bartolomei, P. Toti, P. Mangiavacchi, G. Cevenini, et al. Missing Expression of pRb2/p130 in Human Retinoblastomas Is Associated with Reduced Apoptosis and Lesser Differentiation Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3602 - 3608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E S Bamberger and C W Perrett Angiogenesis in epithelian ovarian cancer Mol. Pathol., December 1, 2002; 55(6): 348 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Millanta, G. Lazzeri, I. Vannozzi, P. Viacava, and A. Poli Correlation of Vascular Endothelial Growth Factor Expression to Overall Survival in Feline Invasive Mammary Carcinomas Vet. Pathol., November 1, 2002; 39(6): 690 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Laack, A. Kohler, C. Kugler, T. Dierlamm, C. Knuffmann, G. Vohwinkel, A. Niestroy, N. Dahlmann, A. Peters, J. Berger, et al. Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer Ann. Onc., October 1, 2002; 13(10): 1550 - 1557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Reinmuth, W. Liu, F. Fan, Y. D. Jung, S. A. Ahmad, O. Stoeltzing, C. D. Bucana, R. Radinsky, and L. M. Ellis Blockade of Insulin-like Growth Factor I Receptor Function Inhibits Growth and Angiogenesis of Colon Cancer Clin. Cancer Res., October 1, 2002; 8(10): 3259 - 3269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. McCabe, K. Boelaert, L. A. Tannahill, A. P. Heaney, A. L. Stratford, J. S. Khaira, S. Hussain, M. C. Sheppard, J. A. Franklyn, and N. J. L. Gittoes Vascular Endothelial Growth Factor, Its Receptor KDR/Flk-1, and Pituitary Tumor Transforming Gene in Pituitary Tumors J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4238 - 4244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Stopeck, M. Sheldon, M. Vahedian, G. Cropp, R. Gosalia, and A. Hannah Results of a Phase I Dose-escalating Study of the Antiangiogenic Agent, SU5416, in Patients with Advanced Malignancies Clin. Cancer Res., September 1, 2002; 8(9): 2798 - 2805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kinuya, A. Kawashima, K. Yokoyama, K. Koshida, S. Konishi, N. Watanabe, N. Shuke, H. Bunko, T. Michigishi, and N. Tonami Cooperative Effect of Radioimmunotherapy and Antiangiogenic Therapy with Thalidomide in Human Cancer Xenografts J. Nucl. Med., August 1, 2002; 43(8): 1084 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Restucci, S. Papparella, P. Maiolino, and G. De Vico Expression of Vascular Endothelial Growth Factor in Canine Mammary Tumors Vet. Pathol., July 1, 2002; 39(4): 488 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Veenendaal, H. Jin, S. Ran, L. Cheung, N. Navone, J. W. Marks, J. Waltenberger, P. Thorpe, and M. G. Rosenblum In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors PNAS, June 11, 2002; 99(12): 7866 - 7871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Witmer, J. Dai, H. A. Weich, G. F.J.M. Vrensen, and R. O. Schlingemann Expression of Vascular Endothelial Growth Factor Receptors 1, 2, and 3 in Quiescent Endothelia J. Histochem. Cytochem., June 1, 2002; 50(6): 767 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lucchi, A. Mussi, G. Fontanini, P. Faviana, A. Ribechini, and C. A. Angeletti Small cell lung carcinoma (SCLC): the angiogenic phenomenon Eur. J. Cardiothorac. Surg., June 1, 2002; 21(6): 1105 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.S. Brock and S.M. Lee Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer Eur. Respir. J., March 1, 2002; 19(3): 557 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Yuan, C.-J. Yu, K.-T. Luh, S.-H. Kuo, Y.-C. Lee, and P.-C. Yang Aberrant p53 Expression Correlates With Expression of Vascular Endothelial Growth Factor mRNA and Interleukin-8 mRNA and Neoangiogenesis in Non-Small-Cell Lung Cancer J. Clin. Oncol., February 15, 2002; 20(4): 900 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Maeno, T. Tanaka, Y. Sando, T. Suga, Y. Maeno, J. Nakagawa, T. Hosono, M. Sato, H. Akiyama, S. Kishi, et al. Stimulation of Vascular Endothelial Growth Factor Gene Transcription by all trans Retinoic Acid through Sp1 and Sp3 Sites in Human Bronchioloalveolar Carcinoma Cells Am. J. Respir. Cell Mol. Biol., February 1, 2002; 26(2): 246 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Koomagi, F. Zintl, A. Sauerbrey, and M. Volm Vascular Endothelial Growth Factor in Newly Diagnosed and Recurrent Childhood Acute Lymphoblastic Leukemia as Measured by Real-Time Quantitative Polymerase Chain Reaction Clin. Cancer Res., November 1, 2001; 7(11): 3381 - 3384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hamma-Kourbali, R. Vassy, A. Starzec, V. Le Meuth-Metzinger, O. Oudar, R. Bagheri-Yarmand, G. Perret, and M. Crepin Vascular Endothelial Growth Factor 165 (VEGF165) Activities Are Inhibited by Carboxymethyl Benzylamide Dextran That Competes for Heparin Binding to VEGF165 and VEGF165{middle dot}KDR Complexes J. Biol. Chem., October 19, 2001; 276(43): 39748 - 39754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Solorzano, Y. D. Jung, C. D. Bucana, D. J. McConkey, G. E. Gallick, G. McMahon, and L. M. Ellis In Vivo Intracellular Signaling as a Marker of Antiangiogenic Activity Cancer Res., October 1, 2001; 61(19): 7048 - 7051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bentzien, I. Struman, J.-F. Martini, J. Martial, and R. Weiner Expression of the Antiangiogenic Factor 16K hPRL in Human HCT116 Colon Cancer Cells Inhibits Tumor Growth in Rag1-/- Mice Cancer Res., October 1, 2001; 61(19): 7356 - 7362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhang, J. P. Gaspard, and D. C. Chung Regulation of Vascular Endothelial Growth Factor by the Wnt and K-ras Pathways in Colonic Neoplasia Cancer Res., August 1, 2001; 61(16): 6050 - 6054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ma, S. Pulfer, S. Li, J. Chu, K. Reed, and J. M. Gallo Pharmacodynamic-mediated Reduction of Temozolomide Tumor Concentrations by the Angiogenesis Inhibitor TNP-470 Cancer Res., July 1, 2001; 61(14): 5491 - 5498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Etoh, H. Inoue, S. Tanaka, G. F. Barnard, S. Kitano, and M. Mori Angiopoietin-2 Is Related to Tumor Angiogenesis in Gastric Carcinoma: Possible in Vivo Regulation via Induction of Proteases Cancer Res., March 1, 2001; 61(5): 2145 - 2153. [Abstract] [Full Text]
|
|
|
|
|
|
M.-D. Tabone, J. Landman-Parker, B. Arcil, M.-C. Coudert, I. Gerota, M. Benbunan, G. Leverger, and C. Dosquet Are Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor Prognostic Indicators in Pediatric Patientswith Malignant Solid Tumors? Clin. Cancer Res., March 1, 2001; 7(3): 538 - 543. [Abstract] [Full Text]
|
|
|
|
|
|
M. Yang, E. Baranov, X.-M. Li, J. W. Wang, P. Jiang, L. Li, A. R. Moossa, S. Penman, and R. M. Hoffman Whole-body and intravital optical imaging of angiogenesis in orthotopically implanted tumors PNAS, February 27, 2001; 98(5): 2616 - 2621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Miller, C. J. Sweeney, and G. W. Sledge Jr Redefining the Target: Chemotherapeutics as Antiangiogenics J. Clin. Oncol., February 15, 2001; 19(4): 1195 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ishikawa, A. P. Heaney, R. Yu, G. A. Horwitz, and S. Melmed Human Pituitary Tumor-Transforming Gene Induces Angiogenesis J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 867 - 874. [Abstract] [Full Text]
|
|
|
|
|
|
R. M. Shaheen, W. W. Tseng, D. W. Davis, W. Liu, N. Reinmuth, R. Vellagas, A. A. Wieczorek, Y. Ogura, D. J. McConkey, K. E. Drazan, et al. Tyrosine Kinase Inhibition of Multiple Angiogenic Growth Factor Receptors Improves Survival in Mice Bearing Colon Cancer Liver Metastases by Inhibition of Endothelial Cell Survival Mechanisms Cancer Res., February 1, 2001; 61(4): 1464 - 1468. [Abstract] [Full Text]
|
|
|
|
|
|
A. Yuan, C.-J. Yu, S.-H. Kuo, W.-J. Chen, F.-Y. Lin, K.-T. Luh, P.-C. Yang, and Y.-C. Lee Vascular Endothelial Growth Factor 189 mRNA Isoform Expression Specifically Correlates With Tumor Angiogenesis, Patient Survival, and Postoperative Relapse in Non-Small-Cell Lung Cancer J. Clin. Oncol., January 15, 2001; 19(2): 432 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z von Marschall, T Cramer, M Hocker, G Finkenzeller, B Wiedenmann, and S Rosewicz Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma Gut, January 1, 2001; 48(1): 87 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Claudio, P. Stiegler, C. M. Howard, C. Bellan, C. Minimo, G. M. Tosi, J. Rak, A. Kovatich, Paola De Fazio, P. Micheli, et al. RB2/p130 Gene-enhanced Expression Down-Regulates Vascular Endothelial Growth Factor Expression and Inhibits Angiogenesis in Vivo Cancer Res., January 1, 2001; 61(2): 462 - 468. [Abstract] [Full Text]
|
|
|
|
|
|
E A Baker, F G Bergin, and D J Leaper Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression Mol. Pathol., December 1, 2000; 53(6): 307 - 312. [Abstract] [Full Text]
|
|
|
|
|
|
G. Zeng, L. Gao, S. Birklé, and R. K. Yu Suppression of Ganglioside GD3 Expression in a Rat F-11 Tumor Cell Line Reduces Tumor Growth, Angiogenesis, and Vascular Endothelial Growth Factor Production Cancer Res., December 1, 2000; 60(23): 6670 - 6676. [Abstract] [Full Text]
|
|
|
|
|
|
D. B. Mendel, R. E. Schreck, D. C. West, G. Li, L. M. Strawn, S. S. Tanciongco, S. Vasile, L. K. Shawver, and J. M. Cherrington The Angiogenesis Inhibitor SU5416 Has Long-lasting Effects on Vascular Endothelial Growth Factor Receptor Phosphorylation and Function Clin. Cancer Res., December 1, 2000; 6(12): 4848 - 4858. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. L. Starnes, B. W. Duncan, J. M. Kneebone, C. H. Fraga, S. States, G. L. Rosenthal, and F. M. Lupinetti Pulmonary microvessel density is a marker of angiogenesis in children after cavopulmonary anastomosis J. Thorac. Cardiovasc. Surg., November 1, 2000; 120(5): 902 - 908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kuniyasu, W. Yasui, H. Shinohara, S. Yano, L. M. Ellis, M. R. Wilson, C. D. Bucana, T. Rikita, E. Tahara, and I. J. Fidler Induction of Angiogenesis by Hyperplastic Colonic Mucosa Adjacent to Colon Cancer Am. J. Pathol., November 1, 2000; 157(5): 1523 - 1535. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
